Global Cell Proliferation Kits Market 2018-2022

Detailed TOC of Global Cell Proliferation Kits Market 2018-2022

Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY APPLICATION
• Overview
• Comparison by application
• Pharmaceutical and biotechnology companies
• Academic institutes and research laboratories
• Others
• Market opportunity by application
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas
• EMEA
• APAC
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Increasing importance of promotional activities
• Emerging economies offering opportunities for growth
• Increasing geriatric population driving biomedical research
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bio-Rad Laboratories
• F. Hoffmann-La Roche
• GENERAL ELECTRIC
• Merck
• PerkinElmer
• Thermo Fisher Scientific
• Other prominent vendors
PART 15: APPENDIX
• List of abbreviations
List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global cell analysis market: Segments
Exhibit 03: Market characteristics
Exhibit 04: Global cell proliferation kits market: Segments
Exhibit 05: Market definition: Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global cell proliferation kits market 2017-2022 ($ millions)
Exhibit 09: Global cell proliferation kits market: Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition: Five forces 2017
Exhibit 18: Market condition: Five forces 2022
Exhibit 19: Global cell proliferation kits market: Segmentation by application 2017-2022 (% share)
Exhibit 20: Comparison by application
Exhibit 21: Global cell proliferation kits market by pharmaceutical and biotechnology companies 2017-2022 ($ millions)
Exhibit 22: Factors driving growth of global pharmaceutical and biotechnology market
Exhibit 23: Global cell proliferation kits market by pharmaceutical and biotechnology companies: Year-over-year growth 2018-2022 (%)
Exhibit 24: Global cell proliferation kits market by academic institutes and research laboratories 2017-2022 ($ millions)
Exhibit 25: Global cell proliferation kits market by academic institutes and research laboratories: Year-over-year growth 2018-2022 (%)
Exhibit 26: Global cell proliferation kits market by others 2017-2022 ($ millions)
Exhibit 27: Global cell proliferation kits market by others: Year-over-year growth 2018-2022 (%)
Exhibit 28: Market opportunity by application
Exhibit 29: Customer landscape
Exhibit 30: Global cell proliferation kits market: Segmentation by geography 2017-2022 (% share)
Exhibit 31: Regional comparison
Exhibit 32: Cell proliferation kits market in Americas 2017-2022 ($ millions)
Exhibit 33: Cell proliferation kits market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 34: Top-three countries in Americas
Exhibit 35: Cell proliferation kits market in EMEA 2017-2022 ($ millions)
Exhibit 36: Cell proliferation kits market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 37: Top-three countries in EMEA
Exhibit 38: Cell proliferation kits market in APAC 2017-2022 ($ millions)
Exhibit 39: Cell proliferation kits market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 40: Top-three countries in APAC
Exhibit 41: Market opportunity
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Bio-Rad Laboratories: Overview
Exhibit 48: Bio-Rad laboratories: Business segments
Exhibit 49: Bio-Rad Laboratories: Organizational developments
Exhibit 50: Bio-Rad Laboratories: Geographic focus
Exhibit 51: Bio-Rad Laboratories: Segment focus
Exhibit 52: Bio-Rad laboratories: Key offerings
Exhibit 53: F. Hoffmann-La Roche: Overview
Exhibit 54: F. Hoffmann-La Roche: Business segments
Exhibit 55: F. Hoffmann-La Roche: Organizational developments
Exhibit 56: F. Hoffmann-La Roche: Geographic focus
Exhibit 57: F. Hoffmann-La Roche: Segment focus
Exhibit 58: F. Hoffmann-La Roche: Key offerings
Exhibit 59: GENERAL ELECTRIC: Overview
Exhibit 60: GENERAL ELECTRIC: Business segments
Exhibit 61: GENERAL ELECTRIC: Organizational developments
Exhibit 62: GENERAL ELECTRIC: Geographic focus
Exhibit 63: GENERAL ELECTRIC: Segment focus
Exhibit 64: GENERAL ELECTRIC: Key offerings
Exhibit 65: Merck: Overview
Exhibit 66: Merck: Business segments
Exhibit 67: Merck: Organizational developments
Exhibit 68: Merck: Geographic focus
Exhibit 69: Merck: Segment focus
Exhibit 70: Merck: Key offerings
Exhibit 71: PerkinElmer: Overview
Exhibit 72: PerkinElmer: Business segments
Exhibit 73: PerkinElmer: Organizational developments
Exhibit 74: PerkinElmer: Geographic focus
Exhibit 75: PerkinElmer: Segment focus
Exhibit 76: PerkinElmer: Key offerings
Exhibit 77: Thermo Fisher Scientific: Overview
Exhibit 78: Thermo Fisher Scientific: Business segments
Exhibit 79: Thermo Fisher Scientific: Organizational developments
Exhibit 80: Thermo Fisher Scientific: Geographic focus
Exhibit 81: Thermo Fisher Scientific: Segment focus
Exhibit 82: Thermo Fisher Scientific: Key offerings